Nikko Asset Management Americas, Inc. Editas Medicine, Inc. Transaction History

Nikko Asset Management Americas, Inc.

$8.64 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $4.78 Million - $7.63 Million	-392,717 Reduced 52.46%	355,836 $4.36 Million
Q2 2022 Aug 04, 2022	SELL	$9.99 - $21.35 $2.83 Million - $6.05 Million	-283,560 Reduced 27.47%	748,553 $8.61 Million
Q1 2022 May 06, 2022	SELL	$14.08 - $27.63 $23.1 Million - $45.4 Million	-1,643,122 Reduced 61.42%	1,032,113 $19.6 Million
Q4 2021 Feb 08, 2022	SELL	$26.55 - $40.57 $42.1 Million - $64.4 Million	-1,587,337 Reduced 37.24%	2,675,235 $71.6 Million
Q3 2021 Nov 09, 2021	SELL	$39.27 - $72.94 $23.8 Million - $44.3 Million	-607,124 Reduced 12.47%	4,262,572 $176 Million
Q2 2021 Aug 09, 2021	BUY	$31.29 - $56.64 $19.2 Million - $34.7 Million	612,140 Added 14.38%	4,869,696 $286 Million
Q1 2021 May 03, 2021	SELL	$39.71 - $90.58 $5.19 Million - $11.8 Million	-130,587 Reduced 2.98%	4,257,556 $179 Million
Q4 2020 Feb 11, 2021	SELL	$27.07 - $84.35 $18.6 Million - $57.9 Million	-685,965 Reduced 13.52%	4,388,143 $308 Million
Q3 2020 Nov 02, 2020	BUY	$28.06 - $37.16 $2.27 Million - $3.01 Million	81,053 Added 1.62%	5,074,108 $142 Million
Q2 2020 Aug 07, 2020	SELL	$18.5 - $34.34 $2.12 Million - $3.94 Million	-114,622 Reduced 2.24%	4,993,055 $146 Million
Q1 2020 Apr 30, 2020	BUY	$14.88 - $32.78 $2.37 Million - $5.23 Million	159,450 Added 3.22%	5,107,677 $101 Million
Q4 2019 Feb 06, 2020	SELL	$19.49 - $32.63 $202,033 - $338,242	-10,366 Reduced 0.21%	4,948,227 $147 Million
Q3 2019 Oct 29, 2019	BUY	$22.49 - $26.81 $41.5 Million - $49.5 Million	1,846,893 Added 59.35%	4,958,593 $113 Million
Q2 2019 Jul 29, 2019	BUY	$20.48 - $27.76 $48.5 Million - $65.8 Million	2,370,395 Added 319.76%	3,111,700 $77 Million
Q1 2019 Apr 30, 2019	BUY	$19.43 - $26.41 $14.4 Million - $19.5 Million	739,079 Added 33202.11%	741,305 $18.1 Million
Q4 2018 Feb 08, 2019	BUY	$18.19 - $31.79 $3,783 - $6,612	208 Added 10.31%	2,226 $51,000
Q3 2018 Oct 15, 2018	BUY	$27.65 - $38.39 $55,797 - $77,471	2,018 New	2,018 $64,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account